AM-1430 is an efficient, highly selective and orally active small molecule inhibitor of PI3Kdelta with an IC50 of 4.6 nM. AM-1430 exhibits IC50s for PI3Kalpha, PI3Kbeta and PI3Kgamma of 14.18, 2.2 and 3.22 µM, respectively. AM-1430 inhibits B cell proliferation and exhibits excellent in vivo activity in pAKT inhibition models and the hemoglobin (KLH) immune response model. AM-1430 can be used for the study of inflammation and autoimmune diseases[1].
Molekulargewicht:
442.45
CAS Nummer:
[1975263-74-1]
Formel:
C23H19FN8O
Target-Kategorie:
PI3K
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
